These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 32541255)

  • 1. Revisiting the Protein C Pathway: An Opportunity for Adjunctive Intervention in COVID-19?
    Mazzeffi M; Chow JH; Amoroso A; Tanaka K
    Anesth Analg; 2020 Sep; 131(3):690-693. PubMed ID: 32541255
    [No Abstract]   [Full Text] [Related]  

  • 2. COVID-19 update: Covid-19-associated coagulopathy.
    Becker RC
    J Thromb Thrombolysis; 2020 Jul; 50(1):54-67. PubMed ID: 32415579
    [No Abstract]   [Full Text] [Related]  

  • 3. 2020 - Year of COVID-19.
    Lillicrap D; Morrissey JH
    J Thromb Haemost; 2020 Sep; 18(9):2081. PubMed ID: 32881334
    [No Abstract]   [Full Text] [Related]  

  • 4. A perfect storm: Root cause analysis of supra-therapeutic anticoagulation with vitamin K antagonists during the COVID-19 pandemic.
    Speed V; Patel RK; Byrne R; Roberts LN; Arya R
    Thromb Res; 2020 Aug; 192():73-74. PubMed ID: 32425265
    [No Abstract]   [Full Text] [Related]  

  • 5. COVID-19 and haemostasis: a position paper from Italian Society on Thrombosis and Haemostasis (SISET).
    Marietta M; Ageno W; Artoni A; De Candia E; Gresele P; Marchetti M; Marcucci R; Tripodi A
    Blood Transfus; 2020 May; 18(3):167-169. PubMed ID: 32281926
    [No Abstract]   [Full Text] [Related]  

  • 6. ISTH DIC subcommittee communication on anticoagulation in COVID-19.
    Thachil J; Juffermans NP; Ranucci M; Connors JM; Warkentin TE; Ortel TL; Levi M; Iba T; Levy JH
    J Thromb Haemost; 2020 Sep; 18(9):2138-2144. PubMed ID: 32881336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coagulopathy and thromboembolic events in patients with SARS-CoV-2 infection: pathogenesis and management strategies.
    Allegra A; Innao V; Allegra AG; Musolino C
    Ann Hematol; 2020 Sep; 99(9):1953-1965. PubMed ID: 32671455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic Inflammatory Response Syndrome Is a Major Contributor to COVID-19-Associated Coagulopathy: Insights From a Prospective, Single-Center Cohort Study.
    Masi P; Hékimian G; Lejeune M; Chommeloux J; Desnos C; Pineton De Chambrun M; Martin-Toutain I; Nieszkowska A; Lebreton G; Bréchot N; Schmidt M; Edouard Luyt C; Combes A; Frere C
    Circulation; 2020 Aug; 142(6):611-614. PubMed ID: 32776849
    [No Abstract]   [Full Text] [Related]  

  • 9. Lessons from the Italian COVID-19 frontline.
    Bellan M; Sainaghi PP; Gavelli F; Patrucco F; Avanzi GC; Pirisi M; Castello LM
    Minerva Med; 2020 Aug; 111(4):303-305. PubMed ID: 33032392
    [No Abstract]   [Full Text] [Related]  

  • 10. The Effect of Anticoagulation Use on Mortality in COVID-19 Infection.
    Salah HM; Naser JA; Calcaterra G; Bassareo PP; Mehta JL
    Am J Cardiol; 2020 Nov; 134():155-157. PubMed ID: 32892991
    [No Abstract]   [Full Text] [Related]  

  • 11. SARS-CoV-2: What is known and what there is to know-Focus on coagulation and lipids.
    Carbone F; Montecucco F; Twickler M
    Eur J Clin Invest; 2020 Jul; 50(7):e13311. PubMed ID: 32511751
    [No Abstract]   [Full Text] [Related]  

  • 12. The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome.
    Ranucci M; Ballotta A; Di Dedda U; Baryshnikova E; Dei Poli M; Resta M; Falco M; Albano G; Menicanti L
    J Thromb Haemost; 2020 Jul; 18(7):1747-1751. PubMed ID: 32302448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coagulopathy and Plausible Benefits of Anticoagulation Among COVID-19 Patients.
    Ahmed SI; Khan S
    Curr Probl Cardiol; 2020 Sep; 45(9):100648. PubMed ID: 32703535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 and coagulative axis: review of emerging aspects in a novel disease.
    Boccia M; Aronne L; Celia B; Mazzeo G; Ceparano M; D'Agnano V; Parrella R; Valente T; Bianco A; Perrotta F
    Monaldi Arch Chest Dis; 2020 May; 90(2):. PubMed ID: 32425013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SGLT-2 inhibitors for COVID-19 - A miracle waiting to happen or just another beat around the bush?
    Chatterjee S
    Prim Care Diabetes; 2020 Oct; 14(5):564-565. PubMed ID: 32493609
    [No Abstract]   [Full Text] [Related]  

  • 16. Anticoagulation with argatroban in patients with acute antithrombin deficiency in severe COVID-19.
    Arachchillage DJ; Remmington C; Rosenberg A; Xu T; Passariello M; Hall D; Laffan M; Patel BV
    Br J Haematol; 2020 Sep; 190(5):e286-e288. PubMed ID: 32516429
    [No Abstract]   [Full Text] [Related]  

  • 17. The unique characteristics of COVID-19 coagulopathy.
    Iba T; Levy JH; Connors JM; Warkentin TE; Thachil J; Levi M
    Crit Care; 2020 Jun; 24(1):360. PubMed ID: 32552865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pros and cons of corticosteroid therapy for COVID-19 patients.
    Mattos-Silva P; Felix NS; Silva PL; Robba C; Battaglini D; Pelosi P; Rocco PRM; Cruz FF
    Respir Physiol Neurobiol; 2020 Sep; 280():103492. PubMed ID: 32659271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erythropoiesis-Stimulating Agent Treatment in Patients With COVID-19.
    Fishbane S; Hirsch JS
    Am J Kidney Dis; 2020 Sep; 76(3):303-305. PubMed ID: 32479920
    [No Abstract]   [Full Text] [Related]  

  • 20. Are statins safe in patients with COVID-19?
    Karalis DG
    J Clin Lipidol; 2020; 14(4):396-397. PubMed ID: 32682805
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.